Glaucoma Crônico Simples - Recentes avanços

Susanna, Remo

doi:10.5935/0004-2749.19960018

Texto completo disponível apenas em PDF.

LITERATURA RECOMENDADA

¹
EPSTEIN, D. L. - Chandler and Grant's. Glaucoma, 3rd edn Philadelphia: Lea & Febiger, 1986.
²
QUIGLEY, H. A.; DUNKLBERG, G. R.; GREEN, W. R. - Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am. J. Ophthalmol. 107: 453, 1989.
³
SOMMERS, A.; KATZ, J.; QUIGLEY, H. A. et al. - Clinically detectable nerve fiber layer atrophy precedes the onset of glaucomatous field loss. Arch. Ophthalmol. 109: 77, 1991.
⁴
CAPRIOLI, J.; MILLER, J. M. - Correlation of Structure and Function in Glaucoma. Quantitative measurements of disc and field. Ophthalmolog 95: 723, 1988.
⁵
SCHERWOOD, M. B.; SPAETH, G. L. - Complications of Glaucoma Therapy New Jersey. Slack, 1990.
⁶
SUSANNA, Jr. R. - Nervo Óptico no Glaucoma. Aspectos Oftalmoscópicos. São Paulo: EDUSP, 1996.
⁷
HIGGINBOTHAN, E. J.; LEE, D. A. - Management of Difficult Glaucomas. Boston: Blackwell Scientific Publications, 1994.
⁸
RITCH, R.; SHIELDS, M. B.; KRUPIN, T. - The Glaucomas St. Louis The C.V. Mosby Company, 1989.
⁹
WATSON, P.; STJERNSCHANTZ, I et al. - A six month, Randomizes, Double-Masked Study Comparing Latanoprost with Timolol in Open Angle Glaucoma and Ocular Hypertension. Ophthalmology, 103: 126-137, 1996.
¹⁰
MORA, J. S.; NGUYER, N. I. L; wasch A. et al. - Trabeculectomy with intra operative sponge 5-fluorouracil. Ophthalmology, 103: 963-970, 1996.
¹¹
CAMRAS, C. B. - Comparision of Latanoprost and Timolol in patients with ocular hypertension and glaucoma: A six month, masked, multicenter trial in the United States. Ophthalmology, 103: 138-147, 1996.
¹²
ALWARD, W. L.; JOHNSON, A. T.; NISHIMURA, D. Y. et al. - Molecular Genetics of glaucoma: Current status. J. Glaucoma, 5: 276-284, 1996.
¹³
PRATA, J. A.; SEACH, S. K. L.; MINCLER, D. S. et al - Postoperative complications and shortterm out come after 5-Fluorouracil or mitomycin-C trabeculectomy. J. Glaucoma 4: 25-31, 1995.
¹⁴
SIGFRIED, C. J.; ROSEMBERG, L. F.; KRUPIN, T. et al - Hipotony after glaucoma filtration surgery. Mechanisms and Incidence. J. Glaucoma, 4: 63-69, 1995.
¹⁵
STEWART, W. C.; LAIBOWITZ, R.; HORWITZ, B. et al. - A 90-day study of the Efficacy and side effects of 0,25% and 0,5% apraclonidine vs timolol. Arch. Ophthalmol., 114: 938-942, 1996.
¹⁶
GREENFIELD, D. S., SUNER, I. J., MILLER, M. P. et al - Endophthalmits after filtering surgery with mitomicyn. Arch. Ophthalmol., 114: 943-949, 1966.
¹⁷
LOTTI, R.; TRAVERSO, C. E.; MURIALDO, U. et al. - Argon laser trabeculoplasty: long-terrn results. Ophthalmic Surg, 26: 127-129, 1995.
¹⁸
ROUHIANEN, H.; LEINO, M.; TERASVIRTA, M. - The effect of some variables on long-terrn results of argon laser trabeculoplasty. Ophthalmologica (Switzerland), 209: 21-24, 1995.
¹⁹
BERGEA, B.; BODIN, L.; SVEDBERGH, B. - Primary argon laser trabeculoplasty vs pilocarpine II: Long-term effects in intraocular pressure and facility of outflow. Study design and additional therapy. Acta Ophthalmol (Copenh) (Denmark), 72: 145-154, Apr 1994.
²⁰
SMITH, M. F.; DOYLE, J. W.; SHERWOOD, M. B. - Comparison of the Baerveld glaucoma implant with the double-plate Molteno drainage implant. Arch. Ophthalmol, 113: 444-447, 1995.
²¹
SUSANNA, R. Jr.; NICOLELA, M. T.; TAKAHASHI, W. Y. - Mitomyin C as adjunctive therapy with glaucoma implant surgery. Ophthalmic Surg, 25: 458-462, 1994.
²²
STRAHLMAN, E.; TIPPING, R.; VOGEL, R. - A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaloxol, intemational Dorzolamide Study group. Arch. Ophthalmol, 113: 1009-1016, 1995.
²³
LIPPA, E. A.; CARLSON, L. E.; EHINGER, B. - Dose response and duration of action of dorzolamide a topical carbonic anhydrase inhibitor. Arch. Ophthalmol, 1120: 495-499, 1992.
²⁴
WILKERSON, M.; CYRLIN, M.; LIPPA, E. A. - Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch. Ophthalmol, 111: 1343-1350, 1993.
²⁵
RANKIN, S. J.; WALMAN, B. E.; BUCKLEY, A. R.; DRANCE, S. M. - Color Doppler imaging and spectral analysis of the optic nerve vasculature in glaucoma. Am. J. Ophthalmol. 119: 685-693, 1995.
²⁶
NETLAND, P. A.; CHATUVERDI, N.; DREYER, E. B. - Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am. J. Ophthalmol. 115: 608-613, 1993.
²⁷
FLAMMER, J. - Psychophysical mechanisms and treatment of vasospastic disordes in norrnaltension glaucoma. Bull Soc Belge Ophthalmol (Belgium), 244: 129-134, 1992.

Datas de Publicação

Publicação nesta coleção
Dec 1996

Este é um artigo publicado em acesso aberto (Open Access) sob a licença Creative Commons Attribution, que permite uso, distribuição e reprodução em qualquer meio, sem restrições desde que o trabalho original seja corretamente citado.

[1] ¹
EPSTEIN, D. L. - Chandler and Grant's. Glaucoma, 3rd edn Philadelphia: Lea & Febiger, 1986.

[2] ²
QUIGLEY, H. A.; DUNKLBERG, G. R.; GREEN, W. R. - Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am. J. Ophthalmol. 107: 453, 1989.

[3] ³
SOMMERS, A.; KATZ, J.; QUIGLEY, H. A. et al. - Clinically detectable nerve fiber layer atrophy precedes the onset of glaucomatous field loss. Arch. Ophthalmol. 109: 77, 1991.

[4] ⁴
CAPRIOLI, J.; MILLER, J. M. - Correlation of Structure and Function in Glaucoma. Quantitative measurements of disc and field. Ophthalmolog 95: 723, 1988.

[5] ⁵
SCHERWOOD, M. B.; SPAETH, G. L. - Complications of Glaucoma Therapy New Jersey. Slack, 1990.

[6] ⁶
SUSANNA, Jr. R. - Nervo Óptico no Glaucoma. Aspectos Oftalmoscópicos. São Paulo: EDUSP, 1996.

[7] ⁷
HIGGINBOTHAN, E. J.; LEE, D. A. - Management of Difficult Glaucomas. Boston: Blackwell Scientific Publications, 1994.

[8] ⁸
RITCH, R.; SHIELDS, M. B.; KRUPIN, T. - The Glaucomas St. Louis The C.V. Mosby Company, 1989.

[9] ⁹
WATSON, P.; STJERNSCHANTZ, I et al. - A six month, Randomizes, Double-Masked Study Comparing Latanoprost with Timolol in Open Angle Glaucoma and Ocular Hypertension. Ophthalmology, 103: 126-137, 1996.

[10] ¹⁰
MORA, J. S.; NGUYER, N. I. L; wasch A. et al. - Trabeculectomy with intra operative sponge 5-fluorouracil. Ophthalmology, 103: 963-970, 1996.

[11] ¹¹
CAMRAS, C. B. - Comparision of Latanoprost and Timolol in patients with ocular hypertension and glaucoma: A six month, masked, multicenter trial in the United States. Ophthalmology, 103: 138-147, 1996.

[12] ¹²
ALWARD, W. L.; JOHNSON, A. T.; NISHIMURA, D. Y. et al. - Molecular Genetics of glaucoma: Current status. J. Glaucoma, 5: 276-284, 1996.

[13] ¹³
PRATA, J. A.; SEACH, S. K. L.; MINCLER, D. S. et al - Postoperative complications and shortterm out come after 5-Fluorouracil or mitomycin-C trabeculectomy. J. Glaucoma 4: 25-31, 1995.

[14] ¹⁴
SIGFRIED, C. J.; ROSEMBERG, L. F.; KRUPIN, T. et al - Hipotony after glaucoma filtration surgery. Mechanisms and Incidence. J. Glaucoma, 4: 63-69, 1995.

[15] ¹⁵
STEWART, W. C.; LAIBOWITZ, R.; HORWITZ, B. et al. - A 90-day study of the Efficacy and side effects of 0,25% and 0,5% apraclonidine vs timolol. Arch. Ophthalmol., 114: 938-942, 1996.

[16] ¹⁶
GREENFIELD, D. S., SUNER, I. J., MILLER, M. P. et al - Endophthalmits after filtering surgery with mitomicyn. Arch. Ophthalmol., 114: 943-949, 1966.

[17] ¹⁷
LOTTI, R.; TRAVERSO, C. E.; MURIALDO, U. et al. - Argon laser trabeculoplasty: long-terrn results. Ophthalmic Surg, 26: 127-129, 1995.

[18] ¹⁸
ROUHIANEN, H.; LEINO, M.; TERASVIRTA, M. - The effect of some variables on long-terrn results of argon laser trabeculoplasty. Ophthalmologica (Switzerland), 209: 21-24, 1995.

[19] ¹⁹
BERGEA, B.; BODIN, L.; SVEDBERGH, B. - Primary argon laser trabeculoplasty vs pilocarpine II: Long-term effects in intraocular pressure and facility of outflow. Study design and additional therapy. Acta Ophthalmol (Copenh) (Denmark), 72: 145-154, Apr 1994.

[20] ²⁰
SMITH, M. F.; DOYLE, J. W.; SHERWOOD, M. B. - Comparison of the Baerveld glaucoma implant with the double-plate Molteno drainage implant. Arch. Ophthalmol, 113: 444-447, 1995.

[21] ²¹
SUSANNA, R. Jr.; NICOLELA, M. T.; TAKAHASHI, W. Y. - Mitomyin C as adjunctive therapy with glaucoma implant surgery. Ophthalmic Surg, 25: 458-462, 1994.

[22] ²²
STRAHLMAN, E.; TIPPING, R.; VOGEL, R. - A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaloxol, intemational Dorzolamide Study group. Arch. Ophthalmol, 113: 1009-1016, 1995.

[23] ²³
LIPPA, E. A.; CARLSON, L. E.; EHINGER, B. - Dose response and duration of action of dorzolamide a topical carbonic anhydrase inhibitor. Arch. Ophthalmol, 1120: 495-499, 1992.

[24] ²⁴
WILKERSON, M.; CYRLIN, M.; LIPPA, E. A. - Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch. Ophthalmol, 111: 1343-1350, 1993.

[25] ²⁵
RANKIN, S. J.; WALMAN, B. E.; BUCKLEY, A. R.; DRANCE, S. M. - Color Doppler imaging and spectral analysis of the optic nerve vasculature in glaucoma. Am. J. Ophthalmol. 119: 685-693, 1995.

[26] ²⁶
NETLAND, P. A.; CHATUVERDI, N.; DREYER, E. B. - Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am. J. Ophthalmol. 115: 608-613, 1993.

[27] ²⁷
FLAMMER, J. - Psychophysical mechanisms and treatment of vasospastic disordes in norrnaltension glaucoma. Bull Soc Belge Ophthalmol (Belgium), 244: 129-134, 1992.

Brasil

Brasil

Glaucoma Crônico Simples - Recentes avanços

LITERATURA RECOMENDADA

Datas de Publicação